Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 82 entries
Sorted by: Best Match Show Resources per page
Do workforce diversity, inclusion practices, & organizational characteristics contribute to organizational innovation? Evidence from the UAE

workforce diversity

Chaudhry IS, Paquibut RY, Tunio MN.
GSID: Fob5hsnhaV4J
IS Chaudhry, RY Paquibut, MN Tunio - Cogent Business & …, 2021 - Taylor & Francis

… This study examines the role of workforce diversity and inclusion practices on organizational innovation in the public and private sectors of the UAE. It further determines whether certain organizational characteristics are more conductive to innovativeness than others. The...

Cite
Chaudhry, I. S., Paquibut, R. Y., & Tunio, M. N. (2021). Do workforce diversity, inclusion practices, & organizational characteristics contribute to organizational innovation? Evidence from the UAE. Cogent Business & Management, 8(1), 1947549.
Chaudhry, Iffat Sabir, Rene Ymbong Paquibut, and Muhammad Nawaz Tunio. "Do workforce diversity, inclusion practices, & organizational characteristics contribute to organizational innovation? Evidence from the UAE." Cogent Business & Management 8.1 (2021): 1947549.
Copy Download .nbib Format: MLA
Determinants of the Sustainable Entrepreneurial Engagement of Youth in Developing Country—An Empirical Evidence from Pakistan

workforce diversity

Chaudhry IS, Jariko MA, Shaikh S, Tunio MN.
GSID: j3t0eyOnWn0J
MN Tunio, IS Chaudhry, S Shaikh, MA Jariko, M Brahmi - Sustainability, 2021 - mdpi.com

The article identifies the motivating factors behind the career preferences of university graduates who chose to engage in sustainable entrepreneurship. In this research, multi …

Cite
Tunio, M. N., Chaudhry, I. S., Shaikh, S., Jariko, M. A., & Brahmi, M. (2021). Determinants of the sustainable entrepreneurial engagement of youth in developing country—An empirical evidence from Pakistan. Sustainability, 13(14), 7764.
Tunio, Muhammad Nawaz, et al. "Determinants of the sustainable entrepreneurial engagement of youth in developing country—An empirical evidence from Pakistan." Sustainability 13.14 (2021): 7764.
Copy Download .nbib Format: MLA
Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases.

Clinical ophthalmology (Auckland, N.Z.)

Al-Qahtani KH, Al Asiri M, Tunio MA, Aljohani NJ, Bayoumi Y, Munir I, AlAyoubi A.
PMID: 25525325
Clin Ophthalmol. 2014 Dec 05;8:2479-84. doi: 10.2147/OPTH.S71708. eCollection 2014.

BACKGROUND: Radioactive iodine 131 ((131)I) therapy has long been used in the treatment of differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications secondary to (131)I therapy are well documented, there is little in the literature addressing nasolacrimal...

Cite
Al-Qahtani KH, Al Asiri M, Tunio MA, et al. Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clin Ophthalmol. 2014;8:2479-84doi: 10.2147/OPTH.S71708.
Al-Qahtani, K. H., Al Asiri, M., Tunio, M. A., Aljohani, N. J., Bayoumi, Y., Munir, I., & AlAyoubi, A. (2014). Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clinical ophthalmology (Auckland, N.Z.), 82479-84. https://doi.org/10.2147/OPTH.S71708
Al-Qahtani, Khalid Hussain, et al. "Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases." Clinical ophthalmology (Auckland, N.Z.) vol. 8 (2014): 2479-84. doi: https://doi.org/10.2147/OPTH.S71708
Al-Qahtani KH, Al Asiri M, Tunio MA, Aljohani NJ, Bayoumi Y, Munir I, AlAyoubi A. Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clin Ophthalmol. 2014 Dec 05;8:2479-84. doi: 10.2147/OPTH.S71708. eCollection 2014. PMID: 25525325; PMCID: PMC4266423.
Copy Download .nbib Format: NLM
Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy.

Case reports in hematology

Maklad AM, Bayoumi Y, Tunio M, Alshakweer W, Dahar MA, Akbar SA.
PMID: 23738161
Case Rep Hematol. 2013;2013:428297. doi: 10.1155/2013/428297. Epub 2013 May 02.

Background. Rosai-Dorfman Disease (RDD) is rare benign hematologic disorder of histiocytes, which usually manifests as painless lymphadenopathy, fever, leukocytosis and hypergammaglobulinemia. Extranodal RDD has been reported in 43% of cases, with skin as commonly involved site followed by head...

Cite
Maklad AM, Bayoumi Y, Tunio M, et al. Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy. Case Rep Hematol. 2013;2013:428297doi: 10.1155/2013/428297.
Maklad, A. M., Bayoumi, Y., Tunio, M., Alshakweer, W., Dahar, M. A., & Akbar, S. A. (2013). Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy. Case reports in hematology, 2013428297. https://doi.org/10.1155/2013/428297
Maklad, Ahmed Marzouk, et al. "Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy." Case reports in hematology vol. 2013 (2013): 428297. doi: https://doi.org/10.1155/2013/428297
Maklad AM, Bayoumi Y, Tunio M, Alshakweer W, Dahar MA, Akbar SA. Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy. Case Rep Hematol. 2013;2013:428297. doi: 10.1155/2013/428297. Epub 2013 May 02. PMID: 23738161; PMCID: PMC3659441.
Copy Download .nbib Format: NLM
Bone mineral density in patients with chronic backache.

JPMA. The Journal of the Pakistan Medical Association

Makhdoom A, Tunio ZH, Saeed M, Memon MA, Tahir SM, Awan S, Khani GM, Anjum P.
PMID: 25989758
J Pak Med Assoc. 2014 Dec;64(12):S119-22.

OBJECTIVE: To evaluate the association of bone mass density with chronic backache.METHODS: The case-control observational study was conducted at Bone Mass Density Assessment Unit, Liaquat University of Medical & Health Sciences Jamshoro from January 2011 to December 2013. Adult...

Cite
Makhdoom A, Tunio ZH, Saeed M, et al. Bone mineral density in patients with chronic backache. J Pak Med Assoc. 2014;64(12):S119-22
Makhdoom, A., Tunio, Z. H., Saeed, M., Memon, M. A., Tahir, S. M., Awan, S., Khani, G. M., & Anjum, P. (2014). Bone mineral density in patients with chronic backache. JPMA. The Journal of the Pakistan Medical Association, 64(12), S119-22.
Makhdoom, Asadullah, et al. "Bone mineral density in patients with chronic backache." JPMA. The Journal of the Pakistan Medical Association vol. 64,12 (2014): S119-22.
Makhdoom A, Tunio ZH, Saeed M, Memon MA, Tahir SM, Awan S, Khani GM, Anjum P. Bone mineral density in patients with chronic backache. J Pak Med Assoc. 2014 Dec;64(12):S119-22. PMID: 25989758.
Copy Download .nbib Format: NLM
Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder.

Case reports in gastrointestinal medicine

Tunio MA, Alasiri M, Ali AM, Alsaeed EF, Shuja M, Fatani H.
PMID: 24396615
Case Rep Gastrointest Med. 2013;2013:946835. doi: 10.1155/2013/946835. Epub 2013 Dec 14.

Background. Small cell carcinoma (SCC) of the gallbladder is a rare entity and is often seen in elderly women. SCC of gallbladder is typically a nonsecretory carcinoid tumor without overt clinical symptoms and is often discovered at advanced stages....

Cite
Tunio MA, Alasiri M, Ali AM, et al. Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder. Case Rep Gastrointest Med. 2013;2013:946835doi: 10.1155/2013/946835.
Tunio, M. A., Alasiri, M., Ali, A. M., Alsaeed, E. F., Shuja, M., & Fatani, H. (2013). Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder. Case reports in gastrointestinal medicine, 2013946835. https://doi.org/10.1155/2013/946835
Tunio, Mutahir A, et al. "Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder." Case reports in gastrointestinal medicine vol. 2013 (2013): 946835. doi: https://doi.org/10.1155/2013/946835
Tunio MA, Alasiri M, Ali AM, Alsaeed EF, Shuja M, Fatani H. Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder. Case Rep Gastrointest Med. 2013;2013:946835. doi: 10.1155/2013/946835. Epub 2013 Dec 14. PMID: 24396615; PMCID: PMC3875121.
Copy Download .nbib Format: NLM
Current challenges and future directions in cardiac imaging.

Journal of the Saudi Heart Association

Wann S, Tunio J.
PMID: 23960604
J Saudi Heart Assoc. 2010 Jul;22(3):121-4. doi: 10.1016/j.jsha.2010.04.010. Epub 2010 May 10.

Imaging is one of the most important accomplishments of medicine during the last 1000 years. The contribution of modern imaging to progress in the delivery of health care is unquestioned. However, we need to refine our use of imaging,...

Cite
Wann S, Tunio J. Current challenges and future directions in cardiac imaging. J Saudi Heart Assoc. 2010;22(3):121-4doi: 10.1016/j.jsha.2010.04.010.
Wann, S., & Tunio, J. (2010). Current challenges and future directions in cardiac imaging. Journal of the Saudi Heart Association, 22(3), 121-4. https://doi.org/10.1016/j.jsha.2010.04.010
Wann, Samuel, and Tunio, Javed. "Current challenges and future directions in cardiac imaging." Journal of the Saudi Heart Association vol. 22,3 (2010): 121-4. doi: https://doi.org/10.1016/j.jsha.2010.04.010
Wann S, Tunio J. Current challenges and future directions in cardiac imaging. J Saudi Heart Assoc. 2010 Jul;22(3):121-4. doi: 10.1016/j.jsha.2010.04.010. Epub 2010 May 10. PMID: 23960604; PMCID: PMC3727514.
Copy Download .nbib Format: NLM
Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis.

Current oncology (Toronto, Ont.)

Tunio MA, Al-Asiri M, Al-Amro A, Bayoumi Y, Fareed M.
PMID: 22876157
Curr Oncol. 2012 Aug;19(4):e280-8. doi: 10.3747/co.19.993.

OBJECTIVE: Bicalutamide is approved as an adjuvant to primary treatments (radical prostatectomy or radiotherapy) or as monotherapy in men with locally advanced, nonmetastatic prostate cancer (pca). However, this treatment induces gynecomastia in most patients, which often results in treatment...

Cite
Tunio MA, Al-Asiri M, Al-Amro A, et al. Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Curr Oncol. 2012;19(4):e280-8doi: 10.3747/co.19.993.
Tunio, M. A., Al-Asiri, M., Al-Amro, A., Bayoumi, Y., & Fareed, M. (2012). Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Current oncology (Toronto, Ont.), 19(4), e280-8. https://doi.org/10.3747/co.19.993
Tunio, M A, et al. "Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis." Current oncology (Toronto, Ont.) vol. 19,4 (2012): e280-8. doi: https://doi.org/10.3747/co.19.993
Tunio MA, Al-Asiri M, Al-Amro A, Bayoumi Y, Fareed M. Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Curr Oncol. 2012 Aug;19(4):e280-8. doi: 10.3747/co.19.993. PMID: 22876157; PMCID: PMC3410840.
Copy Download .nbib Format: NLM
Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?.

Cancer management and research

Asiri MA, Tunio MA, Mohamed R, Bayoumi Y, Alhadab A, Saleh RM, AlArifi MS, Alobaid A.
PMID: 25228820
Cancer Manag Res. 2014 Sep 09;6:339-48. doi: 10.2147/CMAR.S68262. eCollection 2014.

BACKGROUND: The aim was to evaluate whether extended-field concurrent chemoradiation (EF-CCRT) leads to results better than those obtained by standard whole-pelvis concurrent chemoradiation (WP-CCRT) in locally advanced cervical cancer with radiologic negative paraaortic lymph nodes (PALNs).PATIENTS AND METHODS: A...

Cite
Asiri MA, Tunio MA, Mohamed R, et al. Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?. Cancer Manag Res. 2014;6:339-48doi: 10.2147/CMAR.S68262.
Asiri, M. A., Tunio, M. A., Mohamed, R., Bayoumi, Y., Alhadab, A., Saleh, R. M., AlArifi, M. S., & Alobaid, A. (2014). Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?. Cancer management and research, 6339-48. https://doi.org/10.2147/CMAR.S68262
Asiri, Mushabbab Al, et al. "Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?." Cancer management and research vol. 6 (2014): 339-48. doi: https://doi.org/10.2147/CMAR.S68262
Asiri MA, Tunio MA, Mohamed R, Bayoumi Y, Alhadab A, Saleh RM, AlArifi MS, Alobaid A. Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?. Cancer Manag Res. 2014 Sep 09;6:339-48. doi: 10.2147/CMAR.S68262. eCollection 2014. PMID: 25228820; PMCID: PMC4164041.
Copy Download .nbib Format: NLM
Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Tunis MC, Deeks SL.
PMID: 29770021
Can Commun Dis Rep. 2016 Jul 07;42(7):149-151. doi: 10.14745/ccdr.v42i07a03. eCollection 2016 Jul 07.

BACKGROUND: Human papillomavirus (HPV) infections are the most common sexually transmitted infections, and in the absence of vaccination it is estimated that 75 percent of sexually active Canadians will have an HPV infection at some point in their lives....

Cite
Tunis MC, Deeks SL. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Can Commun Dis Rep. 2016;42(7):149-151doi: 10.14745/ccdr.v42i07a03.
Tunis, M. C., Deeks, S. L. (2016). Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Canada communicable disease report = Releve des maladies transmissibles au Canada, 42(7), 149-151. https://doi.org/10.14745/ccdr.v42i07a03
Tunis, M C, et al. "Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 42,7 (2016): 149-151. doi: https://doi.org/10.14745/ccdr.v42i07a03
Tunis MC, Deeks SL. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule. Can Commun Dis Rep. 2016 Jul 07;42(7):149-151. doi: 10.14745/ccdr.v42i07a03. eCollection 2016 Jul 07. PMID: 29770021; PMCID: PMC5757707.
Copy Download .nbib Format: NLM
Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Deeks SL, Tunis MC, Ismail S.
PMID: 29770079
Can Commun Dis Rep. 2017 Jun 01;43(6):138-142. doi: 10.14745/ccdr.v43i07a04. eCollection 2017 Jun 01.

BACKGROUND: Human papillomavirus (HPV) infections are the most common sexually transmitted infections. In the absence of vaccination, it is estimated that 75% of sexually active Canadians will have an HPV infection at some point in their lives. HPV vaccine...

Cite
Deeks SL, Tunis MC, Ismail S. Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. Can Commun Dis Rep. 2017;43(6):138-142doi: 10.14745/ccdr.v43i07a04.
Deeks, S. L., Tunis, M. C., Ismail, S. (2017). Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. Canada communicable disease report = Releve des maladies transmissibles au Canada, 43(6), 138-142. https://doi.org/10.14745/ccdr.v43i07a04
Deeks, S L, et al. "Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 43,6 (2017): 138-142. doi: https://doi.org/10.14745/ccdr.v43i07a04
Deeks SL, Tunis MC, Ismail S. Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. Can Commun Dis Rep. 2017 Jun 01;43(6):138-142. doi: 10.14745/ccdr.v43i07a04. eCollection 2017 Jun 01. PMID: 29770079; PMCID: PMC5864259.
Copy Download .nbib Format: NLM
Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective.

Cureus

Shuja M, Nazli S, Mansha MA, Iqbal A, Mohamed R, Tunio MA, Alsaeed EF, Asiri M, Bayoumi Y.
PMID: 29632747
Cureus. 2018 Feb 02;10(2):e2137. doi: 10.7759/cureus.2137.

INTRODUCTION:  Control of bleeding due to locally invasive disease is of paramount importance in the management of cancer patients. This study was undertaken to explore the outcomes of palliative intent hypofractionated radiation therapy (HRT) in advanced stage pelvic malignancies...

Cite
Shuja M, Nazli S, Mansha MA, et al. Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective. Cureus. 2018;10(2):e2137doi: 10.7759/cureus.2137.
Shuja, M., Nazli, S., Mansha, M. A., Iqbal, A., Mohamed, R., Tunio, M. A., Alsaeed, E. F., Asiri, M., & Bayoumi, Y. (2018). Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective. Cureus, 10(2), e2137. https://doi.org/10.7759/cureus.2137
Shuja, Muhammad, et al. "Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective." Cureus vol. 10,2 (2018): e2137. doi: https://doi.org/10.7759/cureus.2137
Shuja M, Nazli S, Mansha MA, Iqbal A, Mohamed R, Tunio MA, Alsaeed EF, Asiri M, Bayoumi Y. Bleeding in Locally Invasive Pelvic Malignancies: Is Hypofractionated Radiation Therapy a Safe and Effective Non-Invasive Option for Securing Hemostasis? A Single Institution Perspective. Cureus. 2018 Feb 02;10(2):e2137. doi: 10.7759/cureus.2137. PMID: 29632747; PMCID: PMC5880590.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 82 entries